abstract |
The present invention relates to compounds of formulas (I) to (VI) and/or (A) to (H-I), or any subgenus thereof, or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof. The compounds of the present disclosure are useful for modulating androgen receptor activity and for treating cancer, including prostate cancer. |